XTANDI is indicated for the treatment of patients with metastatic castration-resistant prostate cancer who have previously received docetaxel. XTANDI (enzalutamide) capsules should be administered under the supervision of a qualified physician experienced in the uses of cancer chemotherapeutic agents. Brand: XTANDI is manufactured by Astellas Pharma. XTANDI is available as Capsule 40 mg. confirmatory trial.
IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.
For procurement cost of XTANDI (enzalutamide) capsules brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the XTANDI (enzalutamide) capsules cost price in India.
The order for XTANDI (enzalutamide) capsules will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Enzalutamide, sold under the brand name Xtandi, is a nonsteroidal antiandrogen (NSAA) medication which is used in the treatment of prostate cancer. It is indicated for use in conjunction with castration in the treatment of metastatic castration-resistant prostate cancer (mCRPC) and nonmetastatic castration-resistant prostate cancer.
XTANDI (enzalutamide) capsules, for oral use. Initial U.S. Approval: 2012
Generic Name: brigatinib
IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand XTANDI (enzalutamide) capsules on prescription and Import License in Patient's Name only.
For overseas patients, XTANDI (enzalutamide) capsules can be made available in Send your enquiry to find XTANDI (enzalutamide) capsules in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For XTANDI (enzalutamide) Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details
U.S. FDA Grants XTANDI® (enzalutamide) Application Priority Review for the Treatment of Men with Metastatic Hormone-Sensitive Prostate Cancer For More Details
U.S. FDA Approves XTANDI® (enzalutamide) for the Treatment of Men with Non-Metastatic Castration-Resistant Prostate Cancer (CRPC) For More Details